Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GlyTI-M in Children with ADHD
NCT01725737Phase 2Completed
- Sponsor
- Mackay Memorial Hospital
- Start
- Apr 2012
- Primary completion
- Feb 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sarcosine in attention deficit hyperactivity disorder (ADHD), sponsored by Mackay Memorial Hospital. Started Apr 2012; status: completed.
02
Drugs
sarcosine
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on NCT01725737.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01725737.